As of 2025-10-23, the EV/EBITDA ratio of WAVE Life Sciences Ltd (WVE) is -8.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WVE's latest enterprise value is 1,143.27 mil USD. WVE's TTM EBITDA according to its financial statements is -137.06 mil USD. Dividing these 2 quantities gives us the above WVE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.5x - 6.6x | 4.6x |
| Forward P/E multiples | 2.2x - 5.5x | 3.8x |
| Fair Price | (2.13) - (4.73) | (3.62) |
| Upside | -129.7% - -165.9% | -150.4% |
| Date | EV/EBITDA |